Treatment of Coagulase-Negative Staphylococcus Infection
For uncomplicated coagulase-negative staphylococcal infections where the catheter is removed, treat with antibiotics for 5-7 days; however, in low-risk patients without intravascular hardware or prosthetic devices, observation without antibiotics is a safe alternative after catheter removal and confirmation of negative follow-up blood cultures 1.
Treatment Algorithm Based on Clinical Context
Catheter-Related Bloodstream Infection (CRBSI)
When catheter is removed:
- Standard approach: 5-7 days of systemic antibiotics 1
- Low-risk alternative: No antibiotics if ALL criteria met 1, 2:
- No intravascular or orthopedic hardware
- Catheter removed
- Follow-up blood cultures negative (obtained off antibiotics)
- Clinical stability achieved
- Recent high-quality evidence from 2023 supports this approach, showing no increased complications when antibiotics are withheld in low-risk CoNS CRBSI after catheter removal 2
When catheter is retained:
- 10-14 days of systemic antibiotics PLUS antibiotic lock therapy 1
- This scenario should be avoided when possible, as retention significantly complicates management
Important Exception: Staphylococcus lugdunensis
Treat as Staphylococcus aureus with 4-6 weeks of therapy, as this species causes endocarditis and metastatic infections similar to S. aureus 1. This is a critical pitfall—do not assume all CoNS are benign.
Antibiotic Selection
First-Line Options:
- Vancomycin remains appropriate empiric therapy despite concerns about MIC creep 3
- Cefazolin for methicillin-susceptible strains (though 77-90% are methicillin-resistant) 4, 5
Alternative Agents (all CoNS remain susceptible):
The high rate of methicillin resistance (77-90%) means vancomycin or linezolid are typically required 4, 5.
Duration Considerations by Population
Premature infants with uncomplicated CoNS sepsis:
- Short-course treatment (≤96 hours) is noninferior to longer courses when clinical recovery occurs within 24-48 hours and central lines are removed 7
- Relapse rate <1% with short treatment 7
Peritoneal dialysis patients:
- Standard treatment: 2 weeks
- For relapse/repeat episodes: 3 weeks significantly improves cure rates (60% vs lower rates with 2 weeks) 8
Critical Clinical Pearls
Distinguishing true infection from contamination:
- Multiple positive blood cultures from different sites strongly indicate true CRBSI 1
- CoNS are both the most common contaminant AND most common cause of catheter-related infection—clinical correlation is essential
Risk factors for methicillin resistance:
- Recent hospitalization
- Recent antibiotic therapy 8
When to extend therapy beyond standard duration:
- Presence of prosthetic devices
- Immunosuppression
- Persistent fever >72 hours
- Positive follow-up blood cultures 1
Monitoring Requirements
- Obtain follow-up blood cultures 2-4 days after initial positive cultures to document clearance 1
- For patients managed without antibiotics, additional cultures after catheter removal are mandatory to confirm absence of bacteremia 1
- Clinical assessment should identify and eliminate other potential sources of infection 1
The evidence strongly supports that catheter removal is the cornerstone of therapy—when accomplished in low-risk patients, antibiotics may be safely omitted with appropriate monitoring 2, 4.